U.S. markets open in 2 hours 24 minutes
  • S&P Futures

    3,817.75
    -21.25 (-0.55%)
     
  • Dow Futures

    31,450.00
    -15.00 (-0.05%)
     
  • Nasdaq Futures

    12,480.75
    -183.00 (-1.45%)
     
  • Russell 2000 Futures

    2,175.40
    -14.30 (-0.65%)
     
  • Crude Oil

    66.28
    +0.19 (+0.29%)
     
  • Gold

    1,685.10
    -13.40 (-0.79%)
     
  • Silver

    25.25
    -0.04 (-0.15%)
     
  • EUR/USD

    1.1865
    -0.0059 (-0.50%)
     
  • 10-Yr Bond

    1.5540
    0.0000 (0.00%)
     
  • Vix

    27.27
    -1.30 (-4.55%)
     
  • GBP/USD

    1.3832
    +0.0004 (+0.03%)
     
  • USD/JPY

    108.5980
    +0.2160 (+0.20%)
     
  • BTC-USD

    50,405.40
    -200.23 (-0.40%)
     
  • CMC Crypto 200

    1,020.77
    +77.60 (+8.23%)
     
  • FTSE 100

    6,653.22
    +22.70 (+0.34%)
     
  • Nikkei 225

    28,743.25
    -121.07 (-0.42%)
     

Valneva Eyes Head-to-Head Vaccine Trial

Feb.05 -- Thomas Lingelbach, chief executive officer at Valneva SE, discusses the company’s vaccine trials, the difference in processes in working with the U.K. versus the EU and production of the vaccine. He speaks on “Bloomberg Markets: European Open.”